A proton therapy center in San Diego has relaunched with new ownership and management – as well as an expanded physician group – following patient volumes not meeting the prior owner’s projections.
California Proton’s pencil-beam scanning technology precisely targets tumors while protecting healthy tissue and surrounding organs.
Recently, California Proton Therapy Center stepped in as owner.
In 2014, a group with a similar name — California Proton Treatment Center – opened the Scripps Proton Therapy Center, with Scripps Medical Group contracted as the patient care provider and day-to-day manager. But in March of this year, ownership of the center filed for bankruptcy.
In addition, Proton Doctors Professional Corp. has replaced Scripps as the clinical provider.
In late 2016, Scripps embarked on a strategy to boost insurance coverage and reimbursement. The result was a 15 percent to 20 percent increase in patient volumes, equating to around 60 to 70 patients each month in 2017, but still below projections.
Now, it appears the center is looking to increase patient numbers through an expanded network and participation in clinical trials.
“By expanding our existing affiliations with the University of California, Rady Children’s Hospital in San Diego and other healthcare institutions throughout the state, we will increase patient access to the Center and, among other things, enhance our ability to participate in clinical trials and research,” Carl Rossi, medical director of the center, said in a news release.
California Protons is one of only two proton therapy centers in California and 25 nationwide.
“The Center has been recapitalized and the investor group has provided additional financial support to allow the Center to grow,” said James Loughlin, Jr., managing partner at Loughlin Management Partners + Co., a health care turnaround specialist working on the transition.